Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors.
K S S Sai BabaMohd Abdul RehmanJ Pradeep KumarMaira FatimaG S N RajuShantveer G UppinNoorjahan MohammedPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
Our study demonstrated that serum levels of HE4 were significantly higher in malignant group compared to benign and control groups. There is no significant difference between HE4 levels between benign and control groups. These results indicate that HE4 appears as a useful and highly specific biomarker for breast cancer, which can differentiate between malignant and benign tumors.
Keyphrases